Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gonadotropins-IBSA is an IBSA investigational subcutaneous gonadotropin preparation being evaluated for pharmacokinetics and dose proportionality of follicle-stimulating hormone and human chorionic gonadotropin in pituitary down-regulated women. The follicle-stimulating hormone component promotes ovarian follicular development through the follicle-stimulating hormone receptor, while human chorionic gonadotropin provides luteinizing hormone-like activity through the luteinizing hormone/chorionic gonadotropin receptor to support follicular maturation and ovulation-related processes. Registered Phase 1 studies have evaluated both single-dose and multiple-dose administration in infertility and ovarian-stimulation contexts. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06781957))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gonadotropins-IBSA.